Antimicrobial activity of Ro 15-8074, active metabolite of a new oral cephalosporin (Ro 15-8075), against 7,775 recent clinical isolates

Authors:
  • RJR N Jones
    R N Jones
  • PFP C Fuchs
    P C Fuchs
  • ABA L Barry
    A L Barry
  • LAL W Ayers
    L W Ayers
  • EGE H Gerlach
    E H Gerlach
  • TGT L Gavan
    T L Gavan

Abstract
Susceptibility testing of 7,775 recent clinical isolates from four medical centers showed Ro 15-8074 to be 2-to greater than 8-fold more active than either cefaclor or cefuroxime against the Enterobacteriaceae. Ro 15-8074 MICs for 50% of the strains tested were greater than or equal to 32 micrograms/ml for Staphylococcus spp., enterococci, Pseudomonas aeruginosa, and Pseudomonas maltophilia. beta-Lactamase hydrolysis experiments failed to demonstrate significant Ro 15-8074 inactivation by commonly encountered chromosomal or plasmid-mediated enzymes (P99, K1, K14, TEM, and CARB).

This publication has 10 references indexed in Scilit: